Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 14, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2024. Go to the latest filing (Q3 2026)

27.4B USDQ3 2024
Total value of stock positions
27.4B USD
Positions
83
Share of the ten largest
38.6%

The ten largest positions Q3 2024

  1. U.S. Bancorp 5.6%▲ +32.3%
  2. Adobe Inc. 4.9%▲ +15.1%
  3. Apple Inc. 4.1%▲ +5.8%
  4. Philip Morris International 4.0%▼ −17.0%
  5. Visa Inc. 3.5%new
  6. Spotify Technology S A 3.5%▲ +442.7%
  7. Fortive 3.4%▲ +17.5%
  8. Progressive Corporation 3.2%▼ −13.0%
  9. Microsoft 3.2%▼ −10.8%
  10. Api Group Corp 3.1%▼ −4.9%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q3 2024

Positions Q3 2024 per 13F filing, 83 of 83
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 2.8% 4,054,633 755.5M USD −56.4% reduced Q2 2015 38 quarters
Bridgebio Pharma Inc 2.3% 25,120,991 639.6M USD unchanged Q2 2019 22 quarters
Adaptive Biotechnologies Cor 0.6% 29,993,708 153.6M USD unchanged Q2 2019 22 quarters
FTV Fortive 3.4% 11,797,420 931.2M USD +17.5% increased Q3 2019 21 quarters
Api Group Corp 3.1% 25,710,544 849.0M USD −4.9% reduced Q2 2020 18 quarters
Royalty Pharma PLC 1.2% 12,094,021 342.1M USD +1.0% increased Q2 2020 18 quarters
Acadia Healthcare Company In 0.9% 3,701,347 234.7M USD +14.4% increased Q4 2020 16 quarters
AMP Ameriprise Financial 0.4% 243,055 114.2M USD −73.3% reduced Q1 2021 15 quarters
Pharvaris N V 0.2% 3,653,310 67.7M USD unchanged Q1 2021 15 quarters
Zai Lab Ltd 0.2% 1,949,937 47.1M USD −4.3% reduced Q1 2021 15 quarters
Edgewise Therapeutics Inc 0.1% 1,481,146 39.5M USD unchanged Q1 2021 15 quarters
Day One Biopharmaceuticals I 0.1% 2,558,563 35.6M USD unchanged Q2 2021 14 quarters
Rallybio Corp < 0.1% 4,194,777 4.9M USD unchanged Q3 2021 13 quarters
Biomarin Pharmaceutical Inc 2.5% 9,753,293 685.6M USD +38.1% increased Q4 2021 12 quarters
Roivant Sciences Ltd 2.3% 54,099,066 624.3M USD −21.8% reduced Q4 2021 12 quarters
PGR Progressive Corporation 3.2% 3,485,875 884.6M USD −13.0% reduced Q1 2022 11 quarters
Pepgen Inc < 0.1% 1,482,434 12.7M USD unchanged Q2 2022 10 quarters
Trevi Therapeutics Inc < 0.1% 4,400,000 14.7M USD unchanged Q3 2022 9 quarters
CSX CSX Corporation 1.2% 9,351,747 322.9M USD +97.4% increased Q4 2022 8 quarters
Newamsterdam Pharma Company 0.5% 8,024,565 133.2M USD unchanged Q4 2022 8 quarters
WDAY Workday, Inc. 2.9% 3,267,712 798.7M USD −17.5% reduced Q1 2023 7 quarters
Viking Therapeutics Inc 0.2% 721,926 45.7M USD −46.7% reduced Q1 2023 7 quarters
PM Philip Morris International 4.0% 9,052,483 1.1B USD −17.0% reduced Q2 2023 6 quarters
CBRE CBRE Group 0.7% 1,571,735 195.6M USD −56.6% reduced Q2 2023 6 quarters
FCX Freeport-McMoRan 0.6% 3,140,964 156.8M USD −39.9% reduced Q3 2023 5 quarters
USB U.S. Bancorp 5.6% 33,617,210 1.5B USD +32.3% increased Q4 2023 4 quarters
TEAM Atlassian 1.7% 2,974,936 472.4M USD +102.9% increased Q4 2023 4 quarters
HCA HCA Healthcare 1.0% 698,030 283.7M USD +6.7% increased Q4 2023 4 quarters
TMUS T-Mobile US 0.9% 1,150,738 237.5M USD −53.8% reduced Q4 2023 4 quarters
KKR KKR & Co. 0.9% 1,810,751 236.4M USD +232.2% increased Q4 2023 4 quarters
LLY Lilly (Eli) 0.5% 152,038 134.7M USD +5.5% increased Q4 2023 4 quarters
Regal Rexnord Corporation 0.4% 630,121 104.5M USD −43.9% reduced Q4 2023 4 quarters
ADBE Adobe Inc. 4.9% 2,621,398 1.4B USD +15.1% increased Q1 2024 3 quarters
AAPL Apple Inc. 4.1% 4,859,142 1.1B USD +5.8% increased Q1 2024 3 quarters
MSFT Microsoft 3.2% 2,044,429 879.7M USD −10.8% reduced Q1 2024 3 quarters
LVS Las Vegas Sands 1.6% 8,665,215 436.2M USD −56.2% reduced Q1 2024 3 quarters
CPT Camden Property Trust 1.3% 2,959,136 365.5M USD −9.2% reduced Q1 2024 3 quarters
VRT Vertiv 1.0% 2,813,448 279.9M USD +307.9% increased Q1 2024 3 quarters
Integer HLDGS Corp 0.5% 1,110,517 144.4M USD −0.1% reduced Q1 2024 3 quarters
OSCR Oscar Health 0.5% 6,172,132 130.9M USD +4.1% increased Q1 2024 3 quarters
Equitable HLDGS Inc 0.5% 3,050,262 128.2M USD −47.9% reduced Q1 2024 3 quarters
Standard Biotools Inc 0.4% 58,651,170 113.2M USD unchanged Q1 2024 3 quarters
Immunovant Inc 0.2% 2,320,902 66.2M USD unchanged Q1 2024 3 quarters
Longboard Pharmaceuticals In 0.2% 1,969,041 65.6M USD +18.7% increased Q1 2024 3 quarters
Oric Pharmaceuticals Inc 0.1% 4,000,000 41.0M USD unchanged Q1 2024 3 quarters
Spotify Technology S A 3.5% 2,577,629 949.9M USD +442.7% increased Q2 2024 2 quarters
JPM JPMorgan Chase 2.8% 3,696,535 779.5M USD +22.8% increased Q2 2024 2 quarters
DASH DoorDash 1.9% 3,599,305 513.7M USD −35.0% reduced Q2 2024 2 quarters
SHW Sherwin-Williams 1.8% 1,301,656 496.8M USD +219.2% increased Q2 2024 2 quarters
ALL Allstate 1.4% 2,042,102 387.3M USD +274.6% increased Q2 2024 2 quarters
Mcdonalds Corp 1.2% 1,120,649 341.2M USD −40.3% reduced Q2 2024 2 quarters
NVDA Nvidia 1.0% 2,265,322 275.1M USD +63.6% increased Q2 2024 2 quarters
GEV GE Vernova 0.9% 1,013,133 258.3M USD −58.3% reduced Q2 2024 2 quarters
INTU Intuit 0.7% 289,919 180.0M USD −13.7% reduced Q2 2024 2 quarters
CRM Salesforce 0.5% 544,402 149.0M USD +34.4% increased Q2 2024 2 quarters
NFLX Netflix 0.5% 204,981 145.4M USD −78.0% reduced Q2 2024 2 quarters
MMM 3M 0.4% 840,751 114.9M USD −48.9% reduced Q2 2024 2 quarters
CVNA Carvana 0.2% 269,088 46.9M USD −51.4% reduced Q2 2024 2 quarters
Inhibrx Biosciences Inc 0.1% 1,787,705 28.0M USD unchanged Q2 2024 2 quarters
V Visa Inc. 3.5% 3,505,747 963.9M USD new Q3 2024 1 quarter
BAC Bank of America 2.9% 19,959,530 792.0M USD new Q3 2024 1 quarter
Flutter Entmt PLC 2.2% 2,545,376 604.0M USD new Q3 2024 1 quarter
MET MetLife 1.3% 4,487,602 370.1M USD new Q3 2024 1 quarter
Transunion 0.9% 2,400,728 251.4M USD new Q3 2024 1 quarter
VST Vistra Corp. 0.8% 1,837,021 217.8M USD new Q3 2024 1 quarter
GOOGL Alphabet Inc. (Class A) 0.8% 1,277,458 211.9M USD new Q3 2024 1 quarter
ADSK Autodesk 0.8% 762,026 209.9M USD new Q3 2024 1 quarter
AON Aon plc 0.7% 563,027 194.8M USD new Q3 2024 1 quarter
SNPS Synopsys 0.6% 351,523 178.0M USD new Q3 2024 1 quarter
CCL Carnival Corporation 0.6% 9,559,560 176.7M USD new Q3 2024 1 quarter
SBUX Starbucks 0.6% 1,665,162 162.3M USD new Q3 2024 1 quarter
SCHW Charles Schwab Corporation 0.6% 2,339,956 151.7M USD new Q3 2024 1 quarter
ZS Zscaler 0.5% 847,771 144.9M USD new Q3 2024 1 quarter
Teva Pharmaceutical Inds Ltd 0.5% 7,567,533 136.4M USD new Q3 2024 1 quarter
CMCSA Comcast 0.5% 3,092,685 129.2M USD new Q3 2024 1 quarter
TSLA Tesla, Inc. 0.4% 436,272 114.1M USD new Q3 2024 1 quarter
Rogers Communications Inc 0.4% 2,701,058 108.6M USD new Q3 2024 1 quarter
CSGP CoStar Group 0.3% 1,261,195 95.1M USD new Q3 2024 1 quarter
BSX Boston Scientific 0.3% 967,210 81.1M USD new Q3 2024 1 quarter
LI Li Auto 0.2% 2,075,279 53.2M USD new Q3 2024 1 quarter
REGN Regeneron Pharmaceuticals 0.2% 49,870 52.4M USD new Q3 2024 1 quarter
Ginkgo Bioworks Holdings Inc 0.1% 3,577,128 29.2M USD new Q3 2024 1 quarter
Biontech SE < 0.1% 46,294 5.5M USD new Q3 2024 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 23.4%
  • Technology 18.8%
  • Consumer Discretionary 8.0%
  • Industrials 7.0%
  • Consumer Staples 4.0%
  • Communication Services 2.6%
  • Real Estate 2.4%
  • Materials 2.4%
  • Health Care 2.0%
  • Utilities 0.8%
  • not in our coverage 28.6%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close